Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
about
Prevention and treatment of venous thromboembolism during HRT: current perspectives.Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection?Assessing the role of oestrogen in the prevention of cardiovascular disease.Invited review: Pharmacogenetics of estrogen replacement therapy.Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease.Estrogen replacement therapy and cardioprotection: mechanisms and controversies.Efficacy of raloxifene for treatment of menopause: a systematic review.Pharmacogenomics in anticoagulant drug development.Genetic evaluation for coronary artery disease.Pros and cons of thrombophilia testing: pros.Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology.Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.Vascular and metabolic effects of sex steroids: new insights into clinical trials.Menopause: developing a rational treatment plan.Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke.Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.Estrogens and women's health: a scary or a fairy tale?Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease.Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
P2860
Q34140721-D598D792-F028-4499-9A99-30910F504DD8Q34232000-927167F4-ED16-4090-A96F-982DBB50C652Q34329552-D551AFD6-0F09-42E5-B582-D9E494C3E5B5Q34444907-E9C17B0F-ED4C-4C7D-BA08-9C9A2D2D905EQ34459073-DDD3A60C-1A0C-4AD1-A2A2-91BF7341ED2CQ34557438-115DAA2B-BD98-47DB-AB4E-DCDB64E6F60EQ34631937-83F3BCFA-D0AC-4EF9-9705-0FECA45A47FDQ35000929-0B521088-3EFE-4BEC-9095-775902D1FE80Q35179025-4DF6A161-482A-4F71-A1C2-66843CDB9A35Q35181725-3DF18709-27E9-4E06-BDE9-8FF42B136453Q35610515-9E1DEF19-C104-468A-A236-DB522C187CB9Q35642801-363FE21C-55AA-4D7A-A35D-AEA053773BE1Q36888620-E94380E4-B538-4796-8DE6-2F21523F0CAAQ37030684-AA4A8EF8-3FCE-4236-AC91-846D245484A5Q37330613-02057965-C613-49E5-BED2-741B1BB1CEC7Q37989179-6BA8527D-79F1-447F-BFAE-BE60121168F9Q43801855-C1DF20A1-C4E8-48A3-B304-C3A3DD982514Q44426069-B14D1ED8-B45C-4B0F-A17A-11B160037307Q48552885-92A9F4CE-EF19-409F-99A6-DB1DF524EF35
P2860
Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Hormone replacement therapy, p ...... ction in postmenopausal women.
@en
type
label
Hormone replacement therapy, p ...... ction in postmenopausal women.
@en
prefLabel
Hormone replacement therapy, p ...... ction in postmenopausal women.
@en
P2093
P356
P1476
Hormone replacement therapy, p ...... ction in postmenopausal women.
@en
P2093
A Z LaCroix
F R Rosendaal
R N Lemaitre
S R Heckbert
P304
P356
10.1001/JAMA.285.7.906
P407
P577
2001-02-01T00:00:00Z